Statements (65)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:healthcare_organization
|
gptkbp:bfsLayer |
3
|
gptkbp:bfsParent |
gptkb:healthcare_organization
|
gptkbp:affects |
pericardium
|
gptkbp:associated_with |
Ig G4-related diseases
|
gptkbp:can_lead_to |
heart failure
cardiac tamponade chronic pericarditis |
gptkbp:caused_by |
pericardial thickening
|
gptkbp:has_achievements |
myocarditis
pericardial constriction |
gptkbp:hosts |
immunosuppressive therapy
|
https://www.w3.org/2000/01/rdf-schema#label |
Ig G4-related pericarditis
|
gptkbp:is_associated_with |
gptkb:Ig_G4-related_lung_disease
lymphadenopathy systemic symptoms elevated eosinophils other organ involvement |
gptkbp:is_characterized_by |
inflammation
fibrosis elevated Ig G4 levels lymphocytic infiltration |
gptkbp:is_considered |
a chronic condition
a rare condition a rare cause of pericarditis an inflammatory condition |
gptkbp:is_linked_to |
gptkb:Ig_G4-related_kidney_disease
gptkb:Ig_G4-related_retroperitoneal_fibrosis gptkb:Ig_G4-related_thyroiditis Ig G4-related orbital disease |
gptkbp:is_monitored_by |
recurrence
|
gptkbp:is_often_used_in |
middle-aged men
|
gptkbp:is_part_of |
Ig G4-related systemic disease
a spectrum of Ig G4-related disorders |
gptkbp:is_recognized_by |
serological tests
histopathological examination |
gptkbp:is_related_to |
gptkb:Ig_G4-related_sclerosing_disease
|
gptkbp:is_used_for |
fatigue
weight loss fever swelling palpitations dyspnea |
gptkbp:managed_by |
regular follow-up
multidisciplinary approach |
gptkbp:occurs_in |
autoimmune conditions
Ig G4-related cholangitis Ig G4-related pancreatitis patients with elevated serum Ig G4 |
gptkbp:recognizes |
biopsy
|
gptkbp:requires |
surgical intervention
long-term follow-up cardiac evaluation |
gptkbp:social_responsibility |
imaging studies
clinical evaluation imaging techniques other types of pericarditis viral pericarditis |
gptkbp:symptoms |
chest pain
pericardial effusion |
gptkbp:treatment |
gptkb:methotrexate
gptkb:azathioprine biologics corticosteroids antifibrotic agents |